Florian Lordick, Oncologist, Professor of Medicine at the University of Leipzig, Head of Medical Oncology, Director of the Comprehensive Cancer Center Central Germany, shared a post on LinkedIn:
“Today marks a very special milestone for ESMO Gastrointestinal Oncology: our journal has received its first Impact Factor. This achievement is an important recognition of the quality, relevance, and growing influence of the science published in our pages.
As Editors-in-Chief, Irit Ben-Aharon MD, PhD. and I are deeply grateful to everyone who contributed to this success.
A heartfelt thank you to our outstanding Associate Editors and Editorial Board members for their expertise, dedication, and commitment to scientific excellence.
Thank you to the ESMO – European Society for Medical Oncology leadership and staff, and to our partners at Elsevier, whose professionalism and support have been instrumental in building this journal. And above all, thank you to the authors who entrusted us with their exciting and innovative research from the very beginning.
This first Impact Factor is not an endpoint-it is a starting point. Together, we have created a vibrant platform for the global gastrointestinal oncology community, and we are excited about the opportunities that lie ahead.
We look forward to continuing to publish impactful research, foster scientific exchange, and advance outcomes for patients with gastrointestinal cancers worldwide.
The future of ESMO Gastrointestinal Oncology is bright-and this is only the beginning.”
Other articles about ESMO on OncoDaily.